Pura Vida Investments Llc acquired 127,360 shares as Array Biopharma Inc (ARRY)’s stock declined 27.53%. The Pura …
Array Biopharma
Kopp Investment Advisors Llc sold 109,356 shares as Array Biopharma Inc. (ARRY)’s stock declined 27.53%. The Kopp …
Ashmore Group
Given that its average daily volume over the 30 days has been 4.12 million shares a day, this signifies a pretty significant change over the norm. The short interest to Array Biopharma Incorporated's float is 13.52%. On Friday, June 3 the …
88.58% of the stock is currently owned by institutional investors and hedge funds. Get Array Biopharma Inc alerts: Shares of Array Biopharma Inc (NASDAQ:ARRY) opened at 8.14 on Friday. Array Biopharma Inc has a 52-week low of $2.97 …
BNS7d
Investment
Array Biopharma Inc (NASDAQ: ARRY) is having an incredibly strong day in the market today, and for good reason. The company released overwhelmingly positive clinical data. Of course, this led to excitement among investors, leading to …
Stock
This stock has pulled back 41% from highs printed earlier this year. Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule …
Wall Street
Today, Array Biopharma (NASDAQ:ARRY) stock received an upgrade by JPMorgan Chase & Co. from Neutral to …
NASDAQ
Investors generally keep an extensive variety of technical indicators at their disposal for completing technical stock analysis. Array BioPharma Inc. (ARRY ) …
Chyna
Investors in Array BioPharma Inc. (ARRY - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the April 21 st, 2017 $13 Put had some of the highest implied volatility of all …
ZACKS1mon
JPMorgan Chase & Co. upgraded shares of Array Biopharma Inc (NASDAQ:ARRY) from a neutral rating to an overweight rating in a report released on Wednesday, May 3rd. JPMorgan Chase & Co. currently has $10.00 target price on the …